{
    "Symbol": "ABBV",
    "AssetType": "Common Stock",
    "Name": "AbbVie Inc",
    "Description": "AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.",
    "CIK": "1551152",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "PHARMACEUTICAL PREPARATIONS",
    "Address": "1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "271266726000",
    "EBITDA": "31089000000",
    "PERatio": "23.12",
    "PEGRatio": "1.279",
    "BookValue": "9.75",
    "DividendPerShare": "5.71",
    "DividendYield": "0.0384",
    "EPS": "6.63",
    "RevenuePerShareTTM": "32.78",
    "ProfitMargin": "0.204",
    "OperatingMarginTTM": "0.39",
    "ReturnOnAssetsTTM": "0.0991",
    "ReturnOnEquityTTM": "0.724",
    "RevenueTTM": "58054001000",
    "GrossProfitTTM": "41527000000",
    "DilutedEPSTTM": "6.63",
    "QuarterlyEarningsGrowthYOY": "-0.388",
    "QuarterlyRevenueGrowthYOY": "0.016",
    "AnalystTargetPrice": "163.13",
    "TrailingPE": "23.12",
    "ForwardPE": "14.39",
    "PriceToSalesRatioTTM": "4.989",
    "PriceToBookRatio": "18.23",
    "EVToRevenue": "6.04",
    "EVToEBITDA": "13.8",
    "Beta": "0.583",
    "52WeekHigh": "169.46",
    "52WeekLow": "131.49",
    "50DayMovingAverage": "154.25",
    "200DayMovingAverage": "149.01",
    "SharesOutstanding": "1769400000",
    "DividendDate": "2023-05-15",
    "ExDividendDate": "2023-04-13"
}